NCT00452244View on ClinicalTrials.gov

Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

February 28, 2011

Study Completion Date

March 31, 2011

Conditions
Lung Cancer
Interventions
DRUG

simvastatin

Simvastatin 40mg/QD po daily every 3 weeks

DRUG

gefitinib only

gefitinib 250mg/QD po daily every 3 weeks

Trial Locations (1)

Unknown

National Cancer Center, Korea, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV

NCT00452244 - Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter